Labs
Supplements
Log in
Register
Scan Me!
Bariatric Surgery and Type 2: A Fact Sheet from ASMBS
Tag: Type II Diabetes
Chronic Kidney Disease in Type 2 Diabetes
The Six Novel Biomarkers that Predict Type 2 Diabetes
Glucosamine Hinders Type 2
Cognitive Decline, Diabetes, and Obesity -Yes, They are Associated
Providers, regulators explore type 2 therapies for type 1 diabetes
For most children and adults with type 1 diabetes, day-to-day disease management remains difficult despite improvements in insulin formulations and delivery and advancements in diabetes technologies during the past decade.Only 17% of children and 21% of adults with type 1 diabetes meet HbA1c targets outlined in American Diabetes Association guidelines.
Source: Providers, regulators explore type 2 therapies for type 1 diabetes
Medication Nonadherence Common in Patients With T2DM
Routine urine samples can be used to test for medication adherence in patients with type 2 diabetes, according to a study published in the June issue of Diabetes Care.
Source: Medication Nonadherence Common in Patients With T2DM
Abnormal sleep patterns raise HbA1c levels in prediabetes, untreated type 2 diabetes
Adults with prediabetes or untreated type 2 diabetes who sleep fewer than 5 hours or more than 8 hours per night tend to have higher blood glucose levels than those who sleep between 7 and 8 hours, according to findings published in Diabetes Care.
Source: Abnormal sleep patterns raise HbA1c levels in prediabetes, untreated type 2 diabetes
Lifestyle intervention leads to reduced medication in new type 2 diabetes study
A Dutch lifestyle intervention has helped people with type 2 diabetes reduce their medication doses over a six-month period. Compared to before the study, average HbA1c levels dropped by 5 mmol/mol (0.4%) and the number of participants whose HbA1c was below 53 mmol/mol (7%) increased from 36% to 60%.
Source: Lifestyle intervention leads to reduced medication in new type 2 diabetes study
HbA1c, insulin use predict real-world response to GLP-1 receptor agonists in type 2 diabetes
A patient’s response to GLP-1 receptor agonist therapy in type 2 diabetes depends on several pretreatment characteristics, including baseline HbA1c, diabetes duration, age and use of insulin therapy, according to a real-world analysis published in Current Medical Research and Opinion.
Source: HbA1c, insulin use predict real-world response to GLP-1 receptor agonists in type 2 diabetes